Determining if disease management saves money: An introduction to meta-analysis

Journal of Evaluation in Clinical Practice

Volumn 13, Issue 3, 2007, Pages 400-407

  Linden, Ariel ^a,b   Adams, John L ^c  

^a LINDEN CONSULTING GROUP   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c RAND CORPORATION   (United States)

Author keywords

Disease management; Effectiveness; Evaluation; Meta analysis

Indexed keywords

COST CONTROL; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH PROGRAM; HEALTH SERVICE; META ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW;

COST CONTROL; DISEASE MANAGEMENT; HUMANS; META-ANALYSIS; UNITED STATES;

EID: 34249007446     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2006.00721.x     Document Type: Review

References (48)

1. Congressional Budget Office. (2004) An Analysis of the Literature on Disease Management Programs. Washington, DC : Congressional Budget Office. Available at: http://www.cbo.gov/showdoc.cfm?index=5909&sequence=0 (accessed 13 October 2004).
2. Nussbaum S, Selecky C. (2004) Leading Voices in Disease Management Discuss CBO Report, Steps to Demystify Disease Management for Health Plans, Employers, and Government. Washington, D.C., USA : Disease Management Association of America (DMAA). Available at: http://www.dmaa.org/ education_cboreport.asp (accessed 25 April 2007).
3. Diamond F. (2004) DM's cost-effectiveness doubted in CBO report. Managed Care, 13 (11 31 32, 35.
4. DM advocates to CBO: the outcomes are there: industry leaders find fault with new report on savings from DM. Disease Management Advisor, 3 (11 (2004) 124.
5. Bayer, E., Chovan, T. Lemieuz, J. (2005) CBO's Analysis of Potential Savings from Disease Management Programs in Medicare. Washington, D.C., USA : Center for Health Research and Policy at America's Health Insurance Plans (AHIP). Available at: http://www.ahip.org/content/default.aspx?bc=38|72|4361 (accessed 26 February 2005).
6. Landro, L. (2004) Does disease management pay off? Wall Street Journal, 20, D4.
7. Foote, S. M. (2003) Population-based disease management under fee-for-service Medicare. Health Affairs, Web Exclusive (30 July 2003).
8. Nashville Business Journal (2005) American Healthways profits rise 59% in Q2. Nashville Business Journal. Available at: http://www.bizjournals.com/ nashville/stories/2005/03/14/daily35.html (accessed 17 March 2005).
9. Wilson, T. Linden, A. (2004) Measuring diabetes management. Health Affairs, 23 (6 277. Re: Villagra, A. & Ahmed, T. (2004) Effectiveness of a disease management program for patients with diabetes. Health Affairs, 23 (4), 255-266.
10. Linden, A., Wilson, T. W. (2005) Care management for heart failure. Annals of Internal Medicine 142 (5 386. Re: DeBusk, R. F., Miller, N. H., Parker, K. M., Bandura, A., Kraemer, H. C., Cher, D. J., et al. (2004) Care management for low-risk patients with heart failure: a randomized, controlled trial. Annals of Internal Medicine, 141, 606-613.
11. Wilson, T. W. Linden, A. (2005) 'Asthma disease management effectiveness: were the controls equivalent to the cases?' American Journal of Managed Care 3 136. Re: Tinkelman, D. & Wilson, S. (2004) Asthma disease management: regression to the mean or better? American Journal of Managed Care, 10 (12), 948-954.
12. Linden, A. Wilson, T. W. (2005) Letter to the editor. Circulation 112 (1 e11. Re: Galbreath, A. (2004) Long term healthcare and cost outcomes of disease management in a large, randomized community based population with heart failure. Circulation, 110 (23), 3518-3526.
13. Wilson, T. W. Linden, A. (2005) Disease management economic value: unproven? Health Affairs, 24 (2 566 567. Re: Fireman, B., Bartlett, J. & Selby, J. (2004) Can disease management reduce health care costs by improving quality? Health Affairs, 23 (6), 63-75.
14. Ofman, J. J., Badamgarav, E., Henning, J. M., Knight, K., Gano, A. D. Levan, R. K., Gur-Arie, S., Richards, M. S., Hasselblad, V. Weingarten, S. R. (2004) Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review. American Journal of Medicine, 117 (3 182 192.
15. Goetzel, R. Z., Ozminkowski, R. J., Villagra, V. G. Duffy, J. (2005) Return on investment in disease management: a review. Health Care Financing Review, 26, 1 19.
16. Krause DS. (2005) Economic effectiveness of disease management programs: a meta-analysis. Disease Management, 8, 114 134.
17. Pearson, K. (1904) Report on certain enteric fever inoculation statistics. British Medical Journal, 3, 1243 1246.
18. Fisher, R. (1932) A Statistical Methods for Research Workers, 4th edn. Edinburgh : Oliver and Boyd.
19. Yates, F. Cochran, W. G. (1938) The analysis of groups of experiments. Journal of Agricultural Science, 28, 556 580.
20. Beecher, H. K. (1955) The powerful placebo. Journal of the American Medical Association, 159, 1602 1606.
21. Kirsch, I. Sapirstein, G. (1998) Listening to Prozac but hearing placebo: a meta-analysis of antidepressant medication. Prevention & Treatment 1. Article 0002a. Available at: http://journals.apa.org/prevention/volume1/ pre0010002a.html (accessed 26 February 2005).
22. Glass, G. V. (1976) Primary, secondary, and meta-analysis. Educational Researcher, 5, 3 8.
23. Cochrane, A. L. (1979) 1931-71: a critical review, with particular reference to the medical profession. In Medicines for the Year 2000, pp. 1 11. London : Office of Health Economics.
24. Chalmers, I., Enkin, M. Keirse, M. (eds) (1989) Effective Care in Pregnancy and Childbirth. Oxford : Oxford University Press.
25. The Cochrane Library (2005) Issue 3. Available at: http://www.3. interscience.wiley.com/cgi-bin/mrwhome/106568753/HOME (accessed 3 March 2005).
26. Alderson, P., Green, S. Higgins, J. P. T. (eds) (2004) Cochrane Reviewers' Handbook 4.2.2 [updated March 2004]. In The Cochrane Library, Issue 1, 2004. Chichester : John Wiley & Sons.
27. Linden A, Roberts N. (2005) A users guide to the disease management literature: recommendations for reporting and assessing program outcomes. American Journal of Managed Care, 11 (2 81 90.
28. Linden A, Adams J, Roberts N. (2003) An assessment of the total population approach for evaluating disease management program effectiveness. Disease Management, 6 (2 93 102.
29. Linden A, Adams J, Roberts N. (2004) The generalizability of disease management program results: getting from here to there. Managed Care Interface, 17 (7 38 45.
30. Linden A, Adams J, Roberts N. (2006) Evaluating disease management program effectiveness: an introduction to the regression- discontinuity design. Journal of Evaluation in Clinical Practice, 12 (2 124 131.
31. Linden A, Adams J, Roberts N. (2003) Evaluating disease management program effectiveness: an introduction to time series analysis. Disease Management, 6 (4 243 255.
32. Linden A, Adams J. (2006) Evaluating disease management program effectiveness: an introduction to instrumental variables. Journal of Evaluation in Clinical Practice, 12 (2 148 154.
33. Linden A, Adams J, Roberts N. (2005) Using propensity scores to construct comparable control groups for disease management program evaluation. Disease Manage Health Outcomes, 13 (2 107 127.
34. Linden, A., Adams, J. Roberts, N. (2006) Strengthening the case for disease management effectiveness: unhiding the hidden bias. Journal of Evaluation in Clinical Practice, 12 (2 140 147.
35. Yusuf, S., Peto, R., Lewis, J., Collins, R. Sleight, P. (1985) Beta blockade during and after myocardial infarction: an overview of the randomized trials. Progress in Cardiovascular Diseases, 27 (5 335 371.
36. DerSimonian, R. Laird, N. (1986) Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177 188.
37. Greenland, S. (1987) Quantitative methods in the review of epidemiologic literature. Epidemiological Review, 9, 1 30.
38. Berlin, J. A., Laird, N. M., Sacks, H. S. Chalmers, T. C. (1989) A comparison of statistical methods for combining event rates from clinical trials. Statistics in Medicine 2, 141 151.
39. Gavaghan, D. J., Moore, R. A. McQuay, H. J. (2000) An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data. Pain, 85, 415 424.
40. StatsDirect LTD. (2005) StatsDirect statistical software. England. Available at: http://www.statsdirect.com (accessed 17 August 2005).
41. Lewis, S. Clarke, M. (2001) Forest plots: trying to see the wood and the trees. British Medical Journal 322, 1479 1480.
42. Egger, M., Smith, G. D., Schneider, M. Minder, C. (1997) Bias in meta-analysis detected by a simple, graphical test. British Medical Journal, 315, 629 634.
43. Light, R. J. Pillemer, D. B. (1984) Summing up. The Science of Reviewing Research. Cambridge, MA : Harvard University Press.
44. Egger, M., Schneider, M. Smith, G. D. (1998) Meta-analysis spurious precision? Meta-analsysis of observational studies. British Medical Journal, 316, 140 144.
45. National Heart, Lung, and Blood Institute (NHLBI). (2004) Morbidity & Mortality: 2004 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD : US Department of Health and Human Services, Public Health Service, National Institutes of Health.
46. Hunt, S. A., Baker, D. W., Chin, M. H. et al. (2001) ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Journal of the American College of Cardiology, 38, 2102 2112.
47. American Diabetes Association. (2005 Clinical practice recommendations 2005. Diabetes Care, 28 (Suppl. 1 S1 79.
48. National Education Program. (2002) Expert Panel Report II. Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD : US Department of Health and Human Services.